ANI Pharma announces NEW DAY clinical trial results; no specifics in filing

ANI PHARMACEUTICALS INC

Filed Item 8.01 with press release and conference call on NEW DAY Study results.
Presentation attached as Exhibit 99.1; data not reproduced in the 8-K text.
No revenue, EPS, or numeric endpoints provided in the filing body.
Investors should review the full presentation for study outcomes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.